PT Medikaloka Hermina Tbk Announces Earnings Results for the Half Year Ended June 30, 2021
July 30, 2021
Share
PT Medikaloka Hermina Tbk announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was IDR 3,098,249 million compared to IDR 1,732,161 million a year ago. Operating income was IDR 1,014,760 million compared to IDR 236,103 million a year ago. Net income was IDR 544,655 million compared to IDR 104,239 million a year ago. Basic earnings per share from continuing operations was IDR 184.54 compared to IDR 35.09 a year ago. Diluted earnings per share from continuing operations was IDR 182.45 compared to IDR 34.57 a year ago.
PT Medikaloka Hermina Tbk is an Indonesia-based company, which is engaged in offering general hospital services. The Company is focused on providing services for BPJS patients to support government program in Indonesia. The Companyâs services include hospitals, specialties, and featured services. The Companyâs hospitals include Hermina Arcamanik, Hermina Balikpapan, Hermina Banyumanik, Hermina Bekasi, Hermina Bitung, Hermina Bogor, Hermina Ciledug, Hermina Cilegon and Hermina Ciputat. In specialties service, the Company provides anatomical pathology, andrology, anesthesiology, cardiology, clinical microbiology, clinical pathology, dentistry, dermatology and venereology, dietetics, emergency medicine, forensic and medicolegal, internal medicine, medical acupuncture, neurology, and surgery. Its subsidiaries include PT Medikaloka Internusa (M Internusa), PT Medikaloka Sejahtera (M Sejahtera), PT Medikaloka Husada (M Husada), PT Medikaloka Daan Mogot and PT Medikaloka Pasteur (M Pasteur).
PT MEDIKALOKA HERMINA TBK 
